Relmada Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RLMD and other ETFs, options, and stocks.

About RLMD

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. 

CEO
Sergio Traversa
CEOSergio Traversa
Employees
10
Employees10
Headquarters
Coral Gables, Florida
HeadquartersCoral Gables, Florida
Founded
2012
Founded2012
Employees
10
Employees10

RLMD Key Statistics

Market cap
138.91M
Market cap138.91M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
581.70K
Average volume581.70K
High today
$4.77
High today$4.77
Low today
$4.54
Low today$4.54
Open price
$4.54
Open price$4.54
Volume
99.27K
Volume99.27K
52 Week high
$38.68
52 Week high$38.68
52 Week low
$4.50
52 Week low$4.50

Analyst ratings

71%

of 7 ratings
Buy
28.6%
Hold
71.4%
Sell
0%

RLMD Earnings

-$2.44
-$1.63
-$0.81
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 22, After Hours
ActualExpected Mar 22, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.